Generic Formulation Products

Download Brochure

Therapy Area

Anti-Obesity

Immuno Suppressant

Oncology

Oncology / Acromegaly

Central Nervous System

Cardiovascular

Anti-Diabetic

Gastro-Intestinal

Others

Dosage Form

Injectable

Oral

Dossier Status

Available

Filed

Under Development

Therapy Area	Product Name	Strength	Dossier Status
Oncology	Azacitidine	100 mg	Filed
Oncology	Bendamustine	25, 100mg	Filed
Oncology	Bendamustine RTU	180 mg/ 4 ml, 100 mg/ 4 ml	Filed
Oncology	Bortezomib	3.5 mg	Filed
Oncology	Cabazitaxel	60 mg/ 1.5 ml	Filed
Oncology	Carfilzomib	30 mg/ml, 60 mg/ml	Filed
Oncology	Decitabine	50 mg	Filed
Oncology	Eribulin	1 mg/2 ml	Under Development
Oncology	Fulvestrant	50 mg/ml	Filed
Oncology	Fosaprepitant	150 mg/ ml	Filed
Oncology	Liposomal Doxorubicin	20 mg/10 ml ,50 mg/25 ml	Filed
Oncology	Palonosetron	0.075 mg/5 ml, 0.25 mg/ 5 ml	Filed
Oncology	Pemetrexed	100 mg, 500 mg, 1000 mg	Filed
Oncology	Plerixafor	24 mg/1.2 ml	Filed
Oncology	Zoledronic Acid	4 mg/5 ml, 5 mg/100 ml, 4 mg/100 ml	Filed
Oncology	Abiraterone	250 mg	Filed
Oncology	Abiraterone	500 mg	Under Development
Oncology	Capecitabine	150 mg, 500 mg	Filed
Oncology	Dasatinib	20, 50, 70, 80,100 and 140 mg	Filed
Oncology	Enzalutamide	40 mg	Under Development
Oncology	Everolimus	2.5, 5, 7.5, 10 mg	Under Development
Oncology	Lenalidomide	2.5, 5, 10, 15, 20, 25 mg	Filed
Oncology	Lenvatinib	4, 10 mg	Under Development
Oncology	Nilotinib	150, 200 mg	Under Development
Oncology	Palbociclib	75, 100, 125 mg	Filed
Oncology	Pomalidomide	1,2,3,4 mg	Filed
Oncology	Imatinib Mesylate	100 MG AND 400 MG	Filed
Oncology	Carmustine	100 mg/vial	Filed
Oncology	Venetoclax	10 mg, 50 mg and 100 mg	Filed
Oncology	Sorafenib	200 mg	Filed
Oncology	Midostaurin	25 mg	Filed
Oncology	Sunitinib Malate	12.5 mg, 25 mg, 37.5 mg and 50 mg	Filed
Oncology	Nano Paclitaxel	100mg	Under Development
Oncology	Axitinib	1mg, 3mg, 5mg, 7mg	Under Development
Oncology	Cabozantinib	20 mg, 40 mg and 60 mg	Under Development
Oncology	Sunitinib	12.5Mg;25Mg;37.5Mg;50Mg	Filed
Oncology	Tofacitinib XR	Tofacitinib XR	Under Development
Oncology	Pazopanib	200 and 400 mg	Under Development
Oncology	Nintedanib	100 mg & 150 mg	Under Development
Oncology / Acromegaly	Octerotide	10mg, 20mg & 30mg	Under Development
Oncology / Acromegaly	Lanreotide	60mg/0.2mL, 90mg/0.3mL and 120mg/0.5mL	Under Development
Central Nervous System	Glatiramer	20, 40 mg	Filed
Central Nervous System	Sugammadex	100 mg/ml	Filed
Central Nervous System	Pregabalin	25, 50, 75, 100, 150, 200, 225, 300 mg	Filed
Oncology	Fingolimod	0.5 mg	Filed
Cardiovascular	Fondaparinux	2.5, 5, 7.5, 10mg	Filed
Oncology	Dimethyl Fumarate	120mg, 240mg	Under Development
Cardiovascular	Treprostinil	1, 2.5, 5, 10mg/ml	Filed
Cardiovascular	Apixaban	2.5, 5mg	Filed
Cardiovascular	Dabigatran	75 , 110, 150 mg	Filed
Cardiovascular	Rivaroxaban	10, 15, 20 mg	Filed
Cardiovascular	Sacubitril/ Valsartan	24/26, 49/51, 97/103 mg	Filed
Cardiovascular	Ticagrelor	60, 90 mg	Filed
Cardiovascular	Icosapent Ethy	1 g	Filed
Anti-Diabetic	Canagliflozin + Metformin *This product is not available for commercial use. It would be available only for Section 107A purposes.	150 mg/1000 mg, 150 mg/500 mg, 50mg/1000 mg, 50 mg/500 mg	Filed
Anti-Diabetic	Linagliptin	5 mg	Filed
Anti-Diabetic	Linagliptin + Metformin	2.5 mg/500 mg, 2.5 mg/850 mg, 2.5 mg/1000 mg	Filed
Anti-Diabetic	Liraglutide	6mg/ml – 3 ml fill pen	Under Development
Anti-Diabetic	Semaglutide	2mg/1.5mL; 4mg/3mL	Under Development
Anti-Obesity	Liraglutide	6mg/ml – 3 ml fill pen	Under Development
Gastro-Intestinal	Esomeprazole	20, 40mg	Filed
Gastro-Intestinal	Esomeprazole MG + Naproxen Na	20 mg/375 mg, 20 mg/500 mg	Filed
Gastro-Intestinal	Lansoprazole ODT	15 mg and 30 mg	Filed
Immuno Suppressant	Sirolimus	1 mg and 2 mg	Filed
Immuno Suppressant	Tacrolimus	0.5 mg, 1 mg and 5 mg	Filed
Others	Daptomycin	350, 500 mg	Filed
Others	Icatibant	30 mg base /3 ml PFS	Filed
Others	Iron Sucrose	100 mg/5 ml, 200 mg/10 ml, 50 mg/2.5 ml	Filed
Others	阿普斯特	10, 20, 30 mg	Filed
Others	Sevelamer Carbonate	800 mg	Filed
Others	Valganciclovir	450 mg	Filed
Others	Isotretinoin	10mg, 20mg, 30mg and 40mg	Filed
Others	Varenicline	0.5 mg and 1 mg	Filed
Others	Ferric Carboxy Maltose	50mg/mL	Under Development
Others	Teriparatide	0.6 mg/2.4 mL (0.25 mg/mL)	Under Development
Others	Rifaximine	550mg	Under Development
Others	Amphotericin B	50mg	Under Development
Others	Mesalamine	250 and 500 mg	Under Development

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.